Printer Friendly

Conference Call Notice.

Ventana Medical Systems, Inc.

(Nasdaq: VMSI)

Will Host Its Second-Quarter Conference Call For Investors to Discuss Results


Friday, July 20, 2001 at:

10:00 a.m. Eastern, 9:00 a.m. Central, 8:00 a.m. Mountain, 7:00 a.m. Pacific

TO PARTICIPATE: please dial 888-413-4411 at least 5 minutes before start

time The conference call also will be broadcast live on .

REPLAY: If you are unable to participate on the call, a replay will be

available through July 27th at 12:00 midnight Eastern by dialing

888-266-2086, code 5343743, OR by logging onto the Internet at .

RSVP: To assist us in planning for the call, we would greatly appreciate

if you would RSVP.

( ) Yes, I plan to participate in the 2Q call.

E-MAIL OR FAX LIST? Please indicate your preference for future

distribution of press releases and conference call notices:

( ) Keep me on the Fax list.

( ) I'd rather receive everything by E-mail. My E-mail address is

provided below.

( ) I want to be on the Fax list AND the E-mail list. My E-mail address

is below.

( ) I don't want to be on either list going forward.



E-Mail Address:

Fax back to Val Mathias at 312-266-9652 or e-mail to .

Ventana Medical Systems Schedules Second-Quarter Results Conference Call

TUCSON, Ariz., July 10 /PRNewswire/ --

Ventana Medical Systems, Inc. (Nasdaq: VMSI), a leading supplier of automated instrument reagent systems to histology labs and drug discovery labs worldwide, today announced that it will hold a conference call on Friday, July 20, 2001, at 10:00 a.m. EDT to discuss its second-quarter financial and operating results. The call can be accessed via the Internet live and as a replay at . The webcast will be available for replay for a period of 30 days.

Ventana develops, manufactures and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery laboratories worldwide. Ventana's clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases. Ventana's drug discovery systems are used to accelerate the discovery of new drug targets and evaluate the safety of new drug compounds.

For more information on Ventana Medical Systems, Inc. via facsimile at no additional cost, simply dial 1-800-PRO-INFO and enter the stock symbol "VMSI."

Visit the Ventana Medical Systems, Inc. website at

The Molecular Discovery Systems Division has its own website at

COPYRIGHT 2001 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:1USA
Date:Jul 10, 2001
Previous Article:Novell Completes Acquisition of Cambridge Technology Partners.
Next Article:TFS Blackwood Announces That Blackwood Securities Receives Approval to Operate Europe's First Large Scale Nasdaq Daytrading Center in London.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters